Correlation Between Allegroeu and Ryvu Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Allegroeu and Ryvu Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Allegroeu and Ryvu Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Allegroeu SA and Ryvu Therapeutics SA, you can compare the effects of market volatilities on Allegroeu and Ryvu Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Allegroeu with a short position of Ryvu Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Allegroeu and Ryvu Therapeutics.

Diversification Opportunities for Allegroeu and Ryvu Therapeutics

-0.37
  Correlation Coefficient

Very good diversification

The 3 months correlation between Allegroeu and Ryvu is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Allegroeu SA and Ryvu Therapeutics SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ryvu Therapeutics and Allegroeu is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Allegroeu SA are associated (or correlated) with Ryvu Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ryvu Therapeutics has no effect on the direction of Allegroeu i.e., Allegroeu and Ryvu Therapeutics go up and down completely randomly.

Pair Corralation between Allegroeu and Ryvu Therapeutics

Assuming the 90 days trading horizon Allegroeu SA is expected to under-perform the Ryvu Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Allegroeu SA is 2.84 times less risky than Ryvu Therapeutics. The stock trades about -0.3 of its potential returns per unit of risk. The Ryvu Therapeutics SA is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  5,000  in Ryvu Therapeutics SA on August 27, 2024 and sell it today you would earn a total of  1,000.00  from holding Ryvu Therapeutics SA or generate 20.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Allegroeu SA  vs.  Ryvu Therapeutics SA

 Performance 
       Timeline  
Allegroeu SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Allegroeu SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Ryvu Therapeutics 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Ryvu Therapeutics SA are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Ryvu Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Allegroeu and Ryvu Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Allegroeu and Ryvu Therapeutics

The main advantage of trading using opposite Allegroeu and Ryvu Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Allegroeu position performs unexpectedly, Ryvu Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ryvu Therapeutics will offset losses from the drop in Ryvu Therapeutics' long position.
The idea behind Allegroeu SA and Ryvu Therapeutics SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum